Similarly, suppression of MKRN1 (makorin ring finger protein 1) activates AMPK, resulting in increased glucose consumption and reduced lipid accumulation, therefore MKRN1-mediated regulation of AMPK activity has been already considered as an attractive therapeutic approach for the treatment of metabolic disorders[40]. This evidence concerns the gene MKRN1 and Other metabolic disease.